COSCIENS Biopharma Inc. Finished Goods
COSCIENS Biopharma Inc. (CSCIF) had Finished Goods of $102.00 thousand as of 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Notes
ifrs-full:FinishedGoods · last filed 2026-03-25
- 2025-12-31: Finished Goods $102.00K.
- 2025-09-30: Finished Goods $361.00K.
- 2025-06-30: Finished Goods $658.00K.
- 2025-03-31: Finished Goods $197.00K.
| Period end | Finished Goods | Finished Goods as first filed |
|---|---|---|
| 2025-12-31 | $102.00K 20-F · filed 2026-03-25 | |
| 2025-09-30 | $361.00K 6-K · filed 2025-11-12 | |
| 2025-06-30 | $658.00K 6-K · filed 2025-08-14 | |
| 2025-03-31 | $197.00K 6-K · filed 2025-05-13 | |
| 2024-12-31 | $299.00K 20-F · filed 2026-03-25 | |
| 2024-09-30 | $312.00K 6-K · filed 2024-11-12 | |
| 2024-06-30 | $208.00K 6-K · filed 2024-08-13 | |
| 2023-12-31 | $544.00K 20-F · filed 2025-04-09 | |
| 2018-12-31 | $0.00 20-F · filed 2019-04-01 | |
| 2017-12-31 | $554.00K 20-F · filed 2019-04-01 | $556.00K 20-F · filed 2018-03-28 |
| 2016-12-31 | $0.00 20-F · filed 2018-03-28 |